Contraindicated (1)pentobarbital will lessen the extent or influence of cariprazine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. CYP3A4 is liable for the formation and elimination of cariprazine's Lively metabolites.pentobarbital will reduce the level or effect of disopyramide by impacting hepatic/intestinal enzyme CYP